Personality traits and escitalopram treatment outcome in major depression

References

• Bromet E, Andrade LH, Hwang I, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90.
   PubMed Web of Science ®Google Scholar
• Nutt DJ. Rationale for, barriers to, and appropriate medication for the long-term treatment of depression [Consensus Development Conference Research Support, Non-U.S. Gov’t]. J Clin Psychiatry. 2010;71(Suppl. E1):e02.
   PubMedGoogle Scholar
• Kasteenpohja T, Marttunen M, Aalto-Setala T, et al. Outcome of depressive and anxiety disorders among young adults: results from the Longitudinal Finnish Health 2011 Study. Nord J Psychiatry. 2018;72:205–213.
   PubMed Web of Science ®Google Scholar
• Bauer M, Monz BU, Montejo AL, et al. Prescribing patterns of antidepressants in europe: results from the Factors Influencing depression Endpoints Research (FINDER) study. Eur Psychiatry. 2008;23:66–73.
   PubMed Web of Science ®Google Scholar
• Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005;66:974–981.
   PubMed Web of Science ®Google Scholar
• Lenox-Smith A, Martinez JM, Perahia D, et al. Treatment and outcomes for patients with depression who are partial responders to SSRI treatment: post-hoc analysis findings from the FINDER European observational study. J Affect Disord. 2014;169:149–156.
   PubMed Web of Science ®Google Scholar
• Kemp AH, Gordon E, Rush J, et al. Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr. 2008;13:1066–1086.
   PubMed Web of Science ®Google Scholar
• Gudayol-Ferre E, Guadia-Olmos J, Pero-Cebollero M, et al. Prediction of the time-course pattern of remission in depression by using clinical, neuropsychological, and genetic variables. J Affect Disord. 2013;150:1082–1090.
   PubMed Web of Science ®Google Scholar
• Kaneda A, Yasui-Furukori N, Nakagami T, et al. The influence of personality factors on paroxetine response time in patients with major depression. J Affect Disord. 2011;135:321–325.
   PubMed Web of Science ®Google Scholar
• Bagby RM, Quilty LC, Segal ZV, et al. Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Can J Psychiatry. 2008;53:361–370.
   PubMed Web of Science ®Google Scholar
• Mulder RT. Personality pathology and treatment outcome in major depression: a review. Am J Psychiatry. 2002;159:359–371.
   PubMed Web of Science ®Google Scholar
• Eysenck HJ, Eysenck MW. Personality and individual differences: a natural science approach. New York: Plenum Press; 1985.
   Google Scholar
• Costa PT, McCrae RR. Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI). Odessa, FL: Psychological Assessment Resources; 1992.
   Google Scholar
• Quilty LC, De Fruyt F, Rolland J-P, et al. Dimensional personality traits and treatment outcome in patients with major depressive disorder. J Affect Disord. 2008;108:241–250.
   PubMed Web of Science ®Google Scholar
• Shawcross CR, Tyrer P. Influence of personality on response to monoamine-oxidase inhibitors and tricyclic antidepressants. J Psychiatr Res. 1985;19:557–562.
   PubMed Web of Science ®Google Scholar
• Taylor S, Mclean P. Outcome profiles in the treatment of unipolar depression. Behav Res Ther. 1993;31:325–330.
   PubMed Web of Science ®Google Scholar
• Bagby RM, Joffe RT, Parker JDA, et al. Major depression and the Five-Factor Model of personality. J Pers Disord. 1995;9:224–234.
   Web of Science ®Google Scholar
• Petersen T, Papakostas GI, Bottonari K, et al. NEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Res. 2002;109:9–16.
   PubMed Web of Science ®Google Scholar
• Kampman O, Poutanen O, Illi A, et al. Temperament profiles, major depression, and response to treatment with SSRIs in psychiatric outpatients. Eur Psychiatry. 2012;27:245–249.
   PubMed Web of Science ®Google Scholar
• Du LS, Bakish D, Ravindran AV, et al. Does fluoxetine influence major depression by modifying five-factor personality traits? J Affect Disord. 2002;71:235–241.
   PubMed Web of Science ®Google Scholar
• Gunther V, Rufer M, Kersting A, et al. Predicting symptoms in major depression after inpatient treatment: the role of alexithymia. Nord J Psychiatry. 2016;70:392–398.
   PubMed Web of Science ®Google Scholar
• Blom MBJ, Spinhoven P, Hoffman T, et al. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. J Affect Disord. 2007;104:119–126.
   PubMed Web of Science ®Google Scholar
• Gustavsson JP, Bergman H, Edman G, et al. Swedish universities Scales of Personality (SSP): construction, internal consistency and normative data. Acta Psychiatr Scand. 2000;102:217–225.
   PubMed Web of Science ®Google Scholar
• Aluoja A, Voogne H, Maron E, et al. Personality traits measured by the Swedish universities Scales of Personality: factor structure and position within the five-factor model in an Estonian sample. Nord J Psychiatry. 2009;63:231–236.
   PubMed Web of Science ®Google Scholar
• Pendse B, Westrin A, Engstrom G. Temperament traits in seasonal affective disorder, suicide attempters with non-seasonal major depression and healthy controls. J Affect Disord. 1999;54:55–65.
   PubMed Web of Science ®Google Scholar
• Volgsten H, Ekselius L, Poromaa IS, et al. Personality traits associated with depressive and anxiety disorders in infertile women and men undergoing in vitro fertilization treatment. Acta Obstet Gynecol Scand. 2010;89:27–34.
   PubMed Web of Science ®Google Scholar
• Carter GC, Cantrell RA, Zarotsky V, et al. Comprehensive review of factors implicated in the heterogeneity of response in depression. Depress Anxiety. 2012;29:340–354.
   PubMed Web of Science ®Google Scholar
• Vohma U, Raag M, Toru I, et al. Association between personality traits and Escitalopram treatment efficacy in panic disorder. Nord J Psychiatry. 2017;71:433–440.
   PubMed Web of Science ®Google Scholar
• Eller T, Metskula K, Talja I, et al. Thyroid autoimmunity and treatment response to escitalopram in major depression. Nord J Psychiatry. 2010;64:253–257.
   PubMed Web of Science ®Google Scholar
• Maron E, Tammiste A, Kallassalu K, et al. Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression. Eur Neuropsychopharmacol. 2009;19:451–456.
   PubMed Web of Science ®Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22–33.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change [Comparative study]. Br J Psychiatry. 1979;134:382–389.
   PubMed Web of Science ®Google Scholar
• Guy W. NCDEU Assessment Manual for Psychopharmacology. 3rd edn. Rockville (MD): National Institute for Mental Health; 1976.
   Google Scholar
• Brugha T, Bebbington P, Tennant C, et al. The list of threatening experiences - a subset of 12 life event categories with considerable long-term contextual threat. Psychol Med. 1985;15:189–194.
   PubMed Web of Science ®Google Scholar
• Zimmerman M, Posternak MA, Chelminski L. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res. 2004;38:577–582.
   PubMed Web of Science ®Google Scholar
• Haddad PM, Talbot PS, Anderson IM, et al. Managing inadequate antidepressant response in depressive illness. Br Med Bull. 2015;115:183–201.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; [Internet] 2014. Available from: http://www.R-project.org/
   Google Scholar
• Cervenka S, Gustavsson JP, Halldin C, et al. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability. Neuroimage. 2010;50:323–328.
   PubMed Web of Science ®Google Scholar
• Akincigil A, Bowblis JR, Levin C, et al. Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Med Care. 2007;45:363–369.
   PubMed Web of Science ®Google Scholar
• Cantrell CR, Eaddy MT, Shah MB, et al. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes. Med Care. 2006;44:300–303.
   PubMed Web of Science ®Google Scholar
• Sawada N, Uchida H, Suzuki T, et al. Persistence and compliance to antidepressant treatment in patients with depression: a chart review. Bmc Psychiatry. 2009;9:38.
   PubMed Web of Science ®Google Scholar
• Axelsson M. Report on personality and adherence to antibiotic therapy: a population-based study. BMC Psychol. 2013;1:24.
   PubMedGoogle Scholar
• Zugelj U, Zupancic M, Komidar L, et al. Self-reported adherence behavior in adolescent hypertensive patients: the role of illness representations and personality. J Pediatr Psychol. 2010;35:1049–1060.
   PubMed Web of Science ®Google Scholar
• Ode S, Robinson MD. Agreeableness and the self-regulation of negative affect: findings involving the neuroticism/somatic distress relationship. Pers Indiv Differ. 2007;43:2137–2148.
   PubMed Web of Science ®Google Scholar
• Pearman A, Andreoletti C, Isaacowitz DM. Sadness prediction and response: effects of age and agreeableness. Aging Ment Health. 2010;14:355–363.
   PubMed Web of Science ®Google Scholar
• Di Simplicio M, Norbury R, Reinecke A, et al. Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism. Psychol Med. 2014;44:241–252.
   PubMed Web of Science ®Google Scholar
• Watson D, Pennebaker JW. Health complaints, stress, and distress - exploring the central role of negative affectivity. Psychol Rev. 1989;96:234–254.
   PubMed Web of Science ®Google Scholar
• Hirvonen J, Tuominen L, Nagren K, et al. Neuroticism and serotonin 5-HT1A receptors in healthy subjects. Psychiatry Res Neuroimaging. 2015;234:1–6.
   PubMed Web of Science ®Google Scholar
• Miller JM, Hesselgrave N, Ogden RT, et al. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder. Biol Psychiatry. 2013;74:760–767.
   PubMed Web of Science ®Google Scholar